Speeding up the drug discovery process for rare disease patients

<p><span data-contrast="auto">In the</span><a href= "https://www.ddw-online.com/t/in-conversation-series/"><em><span data-contrast="auto"> In Conversation With</span></em> </a><span data-contrast= "auto">series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. </span> <span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p> <p><span data-contrast="auto">In this latest episode, DDW’s Megan Thomas is</span> in conversation with Dr Bruce Bloom, Chief Collaboration Officer at Healx, a biotechnology company using AI drug discovery to develop new treatments for rare diseases, as well as the founder of Cures Within Reach, a global non-profit driving new treatments to patients through repurposing research.</p>